May 1, 2013
UC San Diego Health System is a recipient of the 2012 Outstanding Achievement Award from the American College of Surgeons’ Commission on Cancer. Seventy-nine cancer care programs—three in California—received this national award based on excellence in providing quality care to cancer patients.
March 24, 2014
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center report that bariatric surgery resulting in dramatic weight loss in formerly severely obese women reduces the risk of endometrial (uterine) cancer by 71 percent and as much as 81 percent if normal weight is maintained…
June 19, 2014
A team of scientists, led by principal investigator David D. Schlaepfer, PhD, professor in the Department of Reproductive Medicine at the University of California, San Diego School of Medicine report that small molecule inhibitors to a protein called focal adhesion kinase (FAK) selectively prevent the growth of ovarian cancer cells…
May 25, 2015
Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have now identified six mRNA isoforms (bits of genetic material) produced by ovarian cancer cells but not normal cells, opening up the possibility that they could be used to diagnose early-stage ovarian cancer. What’s more, several…
September 16, 2016
In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program,…
February 15, 2017
A team of 18 University of California San Diego School of Medicine and Moores Cancer Center researchers has developed a new tool to analyze an often overlooked aspect of cancer genetics — an alteration that results in the loss or gain in a copy of a gene. This change, known…
November 20, 2017
The UC San Diego Health International Patient Program was recognized as the 2017 Medical Provider of the Year by the International Travel & Health Insurance Journal (ITIJ). ITIJ recognizes leading health systems from around the globe for their ability to provide comprehensive, culturally-sensitive care to patients from international destinations.
September 21, 2020
Moores Cancer Center at UC San Diego Health is using advanced imaging, genomics, personalized medicine and new therapies to treat patients like Brian McCloskey, who has stage IV prostate cancer.
September 19, 2022
UC San Diego Health now offers a novel therapy option shown to extend the lifespan and improve quality of life for certain patients.
February 5, 2015
…bowel disorder or a gynecological condition, leading to unnecessary surgeries or even death if a patient has a swelling attack in the throat,” explained Dr. Marc Riedl, associate professor of medicine and the center’s clinical director. Emmanuel Dulac, senior vice president of rare diseases at Shire Human Genetics Therapies Inc.,…
